These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12948826)

  • 1. Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa.
    Torres-Bugarín O; Ventura-Aguilar A; Zamora-Perez A; Gómez-Meda BC; Ramos-Ibarra ML; Morgan-Villela G; Gutiérrez-Franco A; Zúñiga-González G
    Mutat Res; 2003 Aug; 539(1-2):177-86. PubMed ID: 12948826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa.
    Torres-Bugarín O; Ventura-Aguilar A; Zamora-Perez A; Gómez-Meda BC; Ramos-Ibarra ML; Morga-Villela G; Gutiérrez-Franco A; Zúñiga-González G
    Mutat Res; 2004 Dec; 565(1):91-101. PubMed ID: 15630804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of 5-fluorouracil, adriamycin, ifosfamide and cisplatin in metastatic adult soft tissue sarcoma: results of a phase II study.
    Jäger E; Klein O; Wächter B; Bernhard H; Dippold W; Meyer zum Büschenfelde KH; Knuth A
    Oncology; 1996; 53(1):58-63. PubMed ID: 8570133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
    Lund B; Hansen OP; Hansen HH; Hansen M
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):26-9. PubMed ID: 1411618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micronuclei and other nuclear anomalies in exfoliated buccal mucosa cells of Mexican women with breast cancer.
    Flores-Garcia A; Torres-Bugarin O; Salvador Velarde-Félix J; Rangel-Villalobos H; Zepeda-Carrillo EA; Rodríguez-Trejo A; Aguíar-García P; Nersesyan A
    J BUON; 2014; 19(4):895-9. PubMed ID: 25536592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
    Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
    J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro models of a three-drug regimen (epirubicin, cisplatin and fluorouracil) for the treatment of colorectal cancer.
    Caliò E; Seminara P; Aronne T; Sbaffi E; Pagani Guazzugli Bonaiuti V; Gargano L; Franchi F
    Chemotherapy; 2001 Dec; 47(6):430-7. PubMed ID: 11786658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
    Sculier JP; Lafitte JJ; Paesmans M; Thiriaux J; Alexopoulos CG; Baumöhl J; Schmerber J; Koumakis G; Florin MC; Zacharias C; Berghmans T; Mommen P; Ninane V; Klastersky J
    Br J Cancer; 2000 Nov; 83(9):1128-35. PubMed ID: 11027424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of paclitaxel and carboplatin versus ifosfamide, etoposide, and carboplatin regimen for treatment of patients with advanced non-small cell lung cancer].
    Li DX; Chen XB
    Ai Zheng; 2002 Apr; 21(4):412-5. PubMed ID: 12452023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
    Colucci G; Gebbia V; Galetta D; Riccardi F; Cariello S; Gebbia N
    Br J Cancer; 1997; 76(11):1509-17. PubMed ID: 9400950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear abnormalities in buccal mucosa cells of patients with type I and II diabetes treated with folic acid.
    Gómez-Meda BC; Zamora-Perez AL; Muñoz-Magallanes T; Sánchez-Parada MG; García Bañuelos JJ; Guerrero-Velázquez C; Sánchez-Orozco LV; Vera-Cruz JM; Armendáriz-Borunda J; Zúñiga-González GM
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Feb; 797():1-8. PubMed ID: 26921015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of genetic damage in buccal epithelium cells of painters: micronucleus, nuclear changes, and repair index.
    Celik A; Diler SB; Eke D
    DNA Cell Biol; 2010 Jun; 29(6):277-84. PubMed ID: 20218900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buccal micronucleus cytome assay of populations under chronic heavy metal and other metal exposure along the Santiago River, Mexico.
    Gómez-Meda BC; Zúñiga-González GM; Sánchez-Orozco LV; Zamora-Perez AL; Rojas-Ramírez JP; Rocha-Muñoz AD; Sobrevilla-Navarro AA; Arellano-Avelar MA; Guerrero-de León AA; Armendáriz-Borunda JS; Sánchez-Parada MG
    Environ Monit Assess; 2017 Sep; 189(10):522. PubMed ID: 28948473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
    Tscherry G; Jacky E; Jost LM; Stahel RA
    Oncology; 2000 Aug; 59(2):110-7. PubMed ID: 10971168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to Combination Chemotherapy With Paclitaxel/Ifosfamide/Platinum Versus Paclitaxel/Platinum for Patients With Metastatic, Recurrent, or Persistent Carcinoma of the Uterine Cervix: A Retrospective Analysis.
    Choi HJ; Paik ES; Choi CH; Kim TJ; Lee YY; Lee JW; Bae DS; Kim BG
    Int J Gynecol Cancer; 2018 Sep; 28(7):1333-1341. PubMed ID: 30045137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.
    Ross P; Nicolson M; Cunningham D; Valle J; Seymour M; Harper P; Price T; Anderson H; Iveson T; Hickish T; Lofts F; Norman A
    J Clin Oncol; 2002 Apr; 20(8):1996-2004. PubMed ID: 11956258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of smoking on the frequencies of micronuclei and other nuclear abnormalities in exfoliated oral cells: a comparative study with different cigarette types.
    Nersesyan A; Muradyan R; Kundi M; Knasmueller S
    Mutagenesis; 2011 Mar; 26(2):295-301. PubMed ID: 21044989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna.
    Dandamudi RK; Aslam S; Walji N; El-Modir A; Fernando I
    Anticancer Res; 2015 Sep; 35(9):4841-7. PubMed ID: 26254376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bio-monitoring for the genotoxic assessment in road construction workers as determined by the buccal micronucleus cytome assay.
    Çelik A; Yildirim S; Ekinci SY; Taşdelen B
    Ecotoxicol Environ Saf; 2013 Jun; 92():265-70. PubMed ID: 23474067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.